Report: Market consolidation, manipulation driving up generic-drug prices
A recent report by the National Center for Policy Analysis (NCPA) found that drug wholesaler price manipulation, coupled with the relationships large drug companies have with drugstores and pharmacies, is having an adverse effect on competition and causing the prices of generic prescription drugs to rise. Read More »